This inventor holds 35 USPTO granted patents and 5 published patent applications and 8 EPO patents, primarily in Terpene Production. Top assignees: Firmenich Sa, University of Kentucky Research Foundation, Other. Active years: 2007-2025.
Location History:
- Collonges-Sous-Saleve, FR (2007 - 2017)
- Geneva, CH (2017 - 2022)
- Satigny, CH (2022 - 2024)
Company Filing History:
33 out of 854 
1 out of 903 
1 out of 834,453 Years Active: 2007-2025
Areas of Expertise:
Title: Innovations by Michel Schalk: Pioneering Methods for Drimane Sesquiterpenes
Introduction
Michel Schalk is a noted inventor based in Geneva, Switzerland, with an impressive portfolio of 32 patents. His work primarily focuses on the biochemical methods for producing valuable compounds, contributing significantly to the field of organic chemistry and biotechnology.
Latest Patents
Among Michel Schalk's latest innovations is the patented method for producing albicanol and/or drimenol. This method involves contacting at least one polypeptide with farnesyl diphosphate (FPP) along with a polypeptide that includes a Haloacid dehalogenase (HAD)-like hydrolase domain and exhibits bifunctional terpene synthase activity. Notably, the method can be executed in vitro or in vivo, and it encompasses amino acid sequences of useful polypeptides along with the nucleic acids encoding them. Additionally, the described process provides genetically modified host cells or organisms capable of expressing these polypeptides, facilitating the production of drimane sesquiterpenes such as albicanol and drimenol.
Career Highlights
Michel Schalk's successful career includes significant roles at prominent institutions, including Firmenich SA and the University of Kentucky Research Foundation. His contributions in these organizations have been pivotal in advancing research in terpenoid synthesis and other related fields.
Collaborations
Throughout his career, Michel has collaborated with esteemed colleagues such as Fabienne Deguerry and Laurent Daviet. These collaborations have fostered an environment of innovation, significantly enhancing the impact of his research and developments.
Conclusion
In conclusion, Michel Schalk stands out as a prominent inventor whose work on the production of drimane sesquiterpenes reflects his expertise and dedication to innovation. With a solid foundation in biochemistry and biotechnology, his contributions continue to have a lasting impact on the scientific community and industry applications alike.